Pharmacy World and Science

, Volume 27, Issue 6, pp 475–477 | Cite as

Fungal Chemoprophylaxis with Fluconazole in Preterm Infants

  • José Manuel Martínez SesmeroEmail author
  • Francisco José Farfán Sedano
  • Teresa Molina García
  • Marta Muro Brussi
  • Javier Sánchez-Rubio Ferrández
  • Raúl Díez Fernández
  • Cristóbal Montojo Guillén
Short Research Article


Introduction: To describe the establishment of a fungal chemoprophylaxis protocol in very low birth weight infants (VLBW). To asses safety, tolerability, and effectiveness of fluconazole administration to these patients.

Method: According to published scientific evidence (search on MEDLINE 1994–2001) inclusion criteria for the protocol were defined: gestational age <28 weeks and birth weight <1500 g. Fluconazole was given intravenously by infusion. A pharmacotherapeutic follow-up of patients included on the protocol was performed for 1 year.

Results: Sixteen patients were included on the protocol, two of them died because of causes not related to the drugs given. Significant drug interactions were not observed. Fluconazole side effects were not reported either. None of the patients who finished the chemoprophylaxis showed signs or symptoms of fungal infection.

Conclusion: Fluconazole chemoprophylaxis in this small number of patients has shown an excellent safety and tolerability profile. The lack of fungal infection points out the possibility of using fluconazole to reduce morbidity and mortality in VLBW.


Fluconazole Fungemia Preterm infant Prophylaxis Very low birth weight infant 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Stoll, BJ, Gordon, T, Korones, SB, Shankaran, S, Tyson, JE, Bauer, CR,  et al. 1996Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research NetworkJ Pediatr1296371PubMedGoogle Scholar
  2. 2.
    Beck-Sague, CM Jarvis, WR. The National Nosocomial Infections Surveillance System1993Secular trends in the epidemiology of nosocomial fungal infections in the United States 1980–1990J Infect Dis167124751PubMedGoogle Scholar
  3. 3.
    Beck-Sague, CM, Azimi, P, Fonseca, SN,  et al. 1994Bloodstream infections in neonatal intensive care unit patients: results of a multicenter studyPediatr infect Dis J1311106PubMedGoogle Scholar
  4. 4.
    Gaynes, RP, Martone, WJ, Culver, DH,  et al. 1991Comparison of rates of nosocomial infections in neonatal intensive care units in United StatesAm J Med91192565Google Scholar
  5. 5.
    Rowen, JL, Rench, MA, Kozinetz, CA, Adams, JM, Baker, CJ 1994Endotracheal colonization with Candida enhances risk of systemic candidiasis in very low birth weight neonatesJ Pediatr12478994PubMedGoogle Scholar
  6. 6.
    Rowen, JL, Atkins, JT, Levy, ML, Baer, SC, Baker, CJ 1995Invasive fungal dermatitis in the 1000 gram neonatePediatrics956827PubMedGoogle Scholar
  7. 7.
    Huang, YC, Li, CC, Lin, TY, Lien, RI, Chou, YH, Wu, JL,  et al. 1998Association of fungal colonization and invasive disease in very low birth weight infantsPediatr Infect Dis J7822532Google Scholar
  8. 8.
    Baley, JE, Kliegman, RM, Faranoff, AA 1984Diseminated fungal infections in very low birth weight infants: therapeutic toxicityPediatrics731537PubMedGoogle Scholar
  9. 9.
    Kossof, EH, Buescher, ES, Karlowicz, MG 1998Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 casesPediatr Infect Dis J175048Google Scholar
  10. 10.
    Kicklighter, SD, Springer, SC, Cox, T, Hulsey, TC, Turner, RB 2001 FebFluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infantPediatrics1072938CrossRefGoogle Scholar
  11. 11.
    Kaufman, D, Boyle, R, Hazen, KC, Patrie, JT, Robinson, M, Donowitz, LG 2001Fluconazole prophylaxis against fungal colonization and infection in preterm infantsN Engl J Med34516606CrossRefPubMedGoogle Scholar
  12. 12.
    Ninane, J 1994A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with hematological or oncological malignancies. Multicentre Study GroupEur J Clin Microbiol Infect Dis133307CrossRefPubMedGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  • José Manuel Martínez Sesmero
    • 1
    Email author
  • Francisco José Farfán Sedano
    • 1
  • Teresa Molina García
    • 1
  • Marta Muro Brussi
    • 2
  • Javier Sánchez-Rubio Ferrández
    • 1
  • Raúl Díez Fernández
    • 1
  • Cristóbal Montojo Guillén
    • 1
  1. 1.Department of PharmacyGetafe University Hospital Ctra.Getafe, MadridSpain
  2. 2.Neonatology Unit, Pediatric DepartmentGetafe University HospitalMadridSpain

Personalised recommendations